Journal of Immunology Research / 2019 / Article / Fig 3

Research Article

Immunomodulatory Effects of Combination Therapy with Bushen Formula plus Entecavir for Chronic Hepatitis B Patients

Figure 3

Relationship between the changes of frequencies of Th1, Treg, and DCs and HBsAg decline. (a) Changes of frequencies of Th1, Treg, and DCs were analyzed before and after treatment in patients with HBsAg decline ≥ 10% of C1-Group. BT: before treatment; AT: after treatment. (b) Changes of frequencies of Th1, Treg, and DCs were analyzed before and after treatment in patients with HBsAg decline ≥ 10% of T1-Group. (c) Changes of frequencies of Th1, Treg, and DCs were analyzed before and after treatment in patients with HBsAg decline ≥ 10% of C2-Group. (d) Changes of frequencies of Th1, Treg, and DCs were analyzed before and after treatment in patients with HBsAg decline ≥ 10% of T2-Group.
(a) Patients with HBsAg decline ≥ 10% in C1-Group
(b) Patients with HBsAg decline ≥ 10% in T1-Group
(c) Patients with HBsAg decline ≥ 10% in C2-Group
(d) Patients with HBsAg decline ≥ 10% in T2-Group

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.